Literature DB >> 28886217

Analysis of restricted mean survival time for length-biased data.

Chi Hyun Lee1, Jing Ning1, Yu Shen1.   

Abstract

In clinical studies with time-to-event outcomes, the restricted mean survival time (RMST) has attracted substantial attention as a summary measurement for its straightforward clinical interpretation. When the data are subject to length-biased sampling, which is frequently encountered in observational cohort studies, existing methods to estimate the RMST are not applicable. In this article, we consider nonparametric and semiparametric regression methods to estimate the RMST under the setting of length-biased sampling. To assess the covariate effects on the RMST, a semiparametric regression model that directly relates the covariates and the RMST is assumed. Based on the model, we develop unbiased estimating equations to obtain consistent estimators of covariate effects by properly adjusting for informative censoring and length bias. Stochastic process theories are used to establish the asymptotic properties of the proposed estimators. We investigate the finite sample performance through simulations and illustrate the methods by analyzing a prevalent cohort study of dementia in Canada.
© 2017, The International Biometric Society.

Entities:  

Keywords:  Length-biased data; Nonparametric estimation; Restricted mean survival time; Semiparametric regression method

Mesh:

Year:  2017        PMID: 28886217      PMCID: PMC5843504          DOI: 10.1111/biom.12772

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  19 in total

1.  Distribution-free inference on contrasts of arbitrary summary measures of survival.

Authors:  Kyle D Rudser; Michael L LeBlanc; Scott S Emerson
Journal:  Stat Med       Date:  2012-02-23       Impact factor: 2.373

2.  Pseudo-partial likelihood for proportional hazards models with biased-sampling data.

Authors:  Wei Yann Tsai
Journal:  Biometrika       Date:  2009-06-24       Impact factor: 2.445

3.  The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice.

Authors:  J O IRWIN
Journal:  J Hyg (Lond)       Date:  1949-06

4.  Use of Irwin's restricted mean as an index for comparing survival in different treatment groups--interpretation and power considerations.

Authors:  T G Karrison
Journal:  Control Clin Trials       Date:  1997-04

5.  Nonparametric estimation for length-biased and right-censored data.

Authors:  Chiung-Yu Huang; Jing Qin
Journal:  Biometrika       Date:  2011-03       Impact factor: 2.445

6.  Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis.

Authors:  Hajime Uno; Brian Claggett; Lu Tian; Eisuke Inoue; Paul Gallo; Toshio Miyata; Deborah Schrag; Masahiro Takeuchi; Yoshiaki Uyama; Lihui Zhao; Hicham Skali; Scott Solomon; Susanna Jacobus; Michael Hughes; Milton Packer; Lee-Jen Wei
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

7.  Maximum Likelihood Estimations and EM Algorithms with Length-biased Data.

Authors:  Jing Qin; Jing Ning; Hao Liu; Yu Shen
Journal:  J Am Stat Assoc       Date:  2011-12-01       Impact factor: 5.033

8.  On the restricted mean survival time curve in survival analysis.

Authors:  Lihui Zhao; Brian Claggett; Lu Tian; Hajime Uno; Marc A Pfeffer; Scott D Solomon; Lorenzo Trippa; L J Wei
Journal:  Biometrics       Date:  2015-08-24       Impact factor: 2.571

Review 9.  Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials.

Authors:  Ludovic Trinquart; Justine Jacot; Sarah C Conner; Raphaël Porcher
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

10.  Statistical methods for analyzing right-censored length-biased data under cox model.

Authors:  Jing Qin; Yu Shen
Journal:  Biometrics       Date:  2009-06-12       Impact factor: 2.571

View more
  2 in total

1.  A technique for approximating transition rates from published survival analyses.

Authors:  Markian A Pahuta; Joel Werier; Eugene K Wai; Roy A Patchell; Doug Coyle
Journal:  Cost Eff Resour Alloc       Date:  2019-07-01

2.  Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma.

Authors:  Jieyi Liang; Tingshan He; Hong Li; Xueqing Guo; Zhiqiao Zhang
Journal:  J Transl Med       Date:  2022-06-28       Impact factor: 8.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.